Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus (Q39887208)

15 September 2017

Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus (English)

1 reference

15 September 2017

0 references

Kazuya Shirato

1

1 reference

15 September 2017

Fumihiro Taguchi

series ordinal

2

1 reference

15 September 2017

language of work or name

English

0 references

publication date

4 February 2009

1 reference

15 September 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

15 September 2017

386

1 reference

15 September 2017

1

1 reference

15 September 2017

88-93

1 reference

Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Distinct types of lung disease caused by functional subsets of antiviral T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

A new class of membrane-bound chemokine with a CX3C motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

The role of the mast cell in the pathophysiology of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Analysis of the interaction between respiratory syncytial virus and lipid-rafts in Hep2 cells during infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Activated mast cells produce interleukin 13.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Establishment of an immature mast cell line from a patient with mast cell leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

The role of virus-specific immunoglobulin E in airway hyperresponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Respiratory syncytial virus infection in immunocompromised adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Respiratory syncytial virus infection in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

A review of vaccine research and development: human acute respiratory infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Evaluation of quantitative and type-specific real-time RT-PCR assays for detection of respiratory syncytial virus in respiratory specimens from children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Age-induced reprogramming of mast cell degranulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Mast cell activation and leukotriene secretion in wheezing infants. Relation to respiratory syncytial virus and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Respiratory syncytial virus infection in lower respiratory tract and asthma attack in hospitalized children in North Hokkaido, Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

The role of respiratory syncytial virus in acute bronchiolitis in small children in northern Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Tumor necrosis factor, other cytokines and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

10.1016/J.VIROL.2009.01.011

7 January 2021

Identifiers

DOI

1 reference

release_fudvyt7prbgvhcnwwnwz2gsi3u

15 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fudvyt7prbgvhcnwwnwz2gsi3u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference